Overview
ERAS market data
Price History
ERAS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.44 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.67 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.33 – $24.28 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $5.6K · P/B 3.25.
Company news
Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS) Investors that a Class Action Lawsuit Has Been Filed Against Erasca and Encourages Investors to Contact the Firm Before August 10thGlobenewswire Inc · Jul 23, 2026, 10:15 PM
Morgan Stanley Maintains Equal-Weight on Erasca, Raises Price Target to $21Benzinga · Jul 20, 2026, 12:37 PM
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application DeadlineGlobenewswire Inc · Jul 15, 2026, 11:15 AM
8-K filing — Erasca, Inc. (ERAS)SEC EDGAR · Jul 14, 2026, 9:03 PM
Erasca Unveils Updated Cancer Candidate Progress, Maps Path Toward Pivotal Cancer TrialsBenzinga · Jul 14, 2026, 6:33 PM
Erasca shares are trading higher after B of A Securities raised its price target on the stock from $16 to $18. The company announced the pricing of its upsized public offering of 31,428,572 shares at $17.50 per share.Benzinga · Jul 14, 2026, 2:10 PM
B of A Securities Maintains Neutral on Erasca, Raises Price Target to $18Benzinga · Jul 14, 2026, 1:43 PM
Erasca Announces Pricing of Upsized Public Offering of Common StockGlobenewswire Inc · Jul 14, 2026, 11:00 AM
Reported Earlier, Erasca Announces Pricing Of Upsized Public Offering Of 31,428,572 Common Shares At $17.50 Per ShareBenzinga · Jul 14, 2026, 7:30 AM
Erasca shares are trading lower after the company announced a $500 million offering. The company filed a prospectus for a mixed-shelf offering.Benzinga · Jul 13, 2026, 8:21 PM